Neurological diseases and disorders / Projects

Second Programme of Community action in the Field of Health 2008-2013
22nd Alzheimer Europe Conference: Changing perceptions, practice and policy [22 AEC]
The Commission Communication on a European initiative on Alzheimer`s disease ingled out four main areas for greater EU collaboration:
1. Acting early to diagnose dementia,
2. A shared European effort ...
The Commission Communication on a European initiative on Alzheimer`s disease ingled out four main areas for greater EU collaboration:
1. Acting early to diagnose dementia,
2. A shared European effort in research,
3. National solidarity and exchange of best care practices,
4. Respecting the rights of people with dementia.

In order to support the actions outlined in the Commission Communication on a European initiative on Alzheimer`s disease and other dementias, the 22nd AE Conference will focus on these four priorities and organise an exchange of information, experiences, projects and best practices in the following areas:
1. Medical and scientific update (early diagnosis, prevention, epidemiology)
2. Social and care aspects (psycho-social interventions, care services, stigma and discrimination, integration of Alzheimer`s disease in mental health promotion activities)
3. Legal and ethical issues (guardianship systems, consent, advance directives, patients` rights)
4. Dementia strategies and policies (public health impact of dementia, national plans, financing of care, carer support measures, image of dementia).

In all areas, AE will identify key note speakers to provide state of the art presentations on the current knowledge and understanding, whilst inviting presenters to submit abstracts on ongoing and recently finalised research, projects and experiences.

In addition, AE will collaborate with EU funded initiatives to share the progress and results of research initiatives of programmes and projects like the Joint Programming Initiative on Neurodegenerative Disease, the Joint Action (ALCOVE-Alzheimer COoperation and Valuation in Europe), projects supported under the FP7 and AAL Programmes and by the Innovative Medicines Initiative (PharmaCog).


Start date: 04/10/2012 - End date: 04/10/2013

Call: Generate And Disseminate Health Information And Knowledge (Hi-2010)
Topic: Neurological diseases and disorders
Second Programme of Community action in the Field of Health 2008-2013
Surveillance of Cerebral Palsy in Europe: best practice in monitoring, understanding inequality and dissemination of knowledge [SCPE-NET ]
This project aims to improve the health and wellbeing of children with Cerebral Palsy (CP) in all countries within Europe. It aims to do this by developing guidance on best practice for the care of ch...
This project aims to improve the health and wellbeing of children with Cerebral Palsy (CP) in all countries within Europe. It aims to do this by developing guidance on best practice for the care of children with CP for use by both health professionals and lay carers (e.g. parents), and by improvements in the collection, recording, description and use of clinical and epidemiological data.
Start date: 15/10/2009 - End date: 15/12/2012

Call: Generate And Disseminate Health Information And Knowledge (Hi-2008)
Topic: Neurological diseases and disorders
Second Programme of Community action in the Field of Health 2008-2013
24th AE Conference: [24 AEC]
The Conference is fully in line with the areas singled out in the Commission Communication on a European initiative on Alzheimer`s disease for greater EU collaboration, namely 1. Acting early to diagn...
The Conference is fully in line with the areas singled out in the Commission Communication on a European initiative on Alzheimer`s disease for greater EU collaboration, namely 1. Acting early to diagnose dementia, 2. A shared European effort in research, 3. National solidarity and exchange of best care practices, 4. Respecting the rights of people with dementia.

In addition, the Conference supports key aspects of the European Innovation Partnership on Active and Healthy Ageing in the fields of Integrated care, Prevention, Age friendly society and Innovative solutions.

In order to support the actions outlined above, the 24th AE Conference will focus on and organise an exchange of information, experiences, projects and best practices in the following areas:
1. Rights (rights and responsibilities, proxy decision making, consent and advance directives, ethical issues), 2. Policy (dementia strategies, post diagnostic support, socio-economic cost of dementia, prevention), 3. People with dementia (involving people with dementia, peer support groups, dementia friendly communities, perceptions and image of dementia), 4. Care (home care, residential care, hospital care, palliative care).

In all areas, AE will identify keynote speakers to provide state of the art presentations on the current knowledge and understanding, whilst inviting presenters to submit abstracts on ongoing and recently finalised research, projects and experiences.

In addition, AE will collaborate with EU funded initiatives to share the progress and results of research initiatives of programmes and projects like the Joint Programme for Neurodegenerative Diseases Research, the Joint Action (ALCOVE-Alzheimer COoperation and Valuation in Europe), projects supported under the FP7 and AAL Programmes and by the Innovative Medicines Initiative.
Start date: 22/10/2014 - End date: 22/10/2015

Call: Generate And Disseminate Health Information And Knowledge (Hi-2013)
Topic: Neurological diseases and disorders
First Programme of Community action in the field of public health (2003-2008)
European Network of Surveillance on risk factors for Autism and Cerebral Palsy [ENSACP]
The general objective of the proposal is to improve the quality of life of children affected by ASD and CP by developing a better understanding of pre- and perinatal risk factors and their role in the...
The general objective of the proposal is to improve the quality of life of children affected by ASD and CP by developing a better understanding of pre- and perinatal risk factors and their role in the prevalence trends of ASD and CP in Europe. The ENSACP project is a fundamental step in this effort and the strategic objectives are:
- To improve the information availability for pre- and perinatal risk factors and biomarkers for ASD and CP.
- To improve the accessibility of children affected by ASD and CP to appropriate treatment.
- To facilitate the preparation of analytical studies for a better understanding of the link between risk factors and children affected by ASD and CP.
Start date: 29/12/2007 - End date: 29/03/2010

Call: Health Information (Hi 2006)
Topic: Neurological diseases and disorders